Literature DB >> 22531688

Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update.

Nelson G Ordóñez1.   

Abstract

Thyroid transcription factor-1 (TTF-1) is a tissue-specific transcription factor that plays a critical role in the normal development of embryonic epithelial cells of the thyroid and lung. Because TTF-1 expression is highly restricted to epithelial tumors arising in these organs, it is, at present, one of the immunohistochemical markers most commonly used to assist in the differential diagnosis of carcinomas of the lung and thyroid. Recent studies, however, have reported that TTF-1 is not as specific for lung and thyroid carcinomas as was previously thought as it can be found to be expressed, although much less frequently, in some carcinomas arising in other organs, such as the ovaries, endometrium, colon, and breast, as well as in some tumors of the central nervous system. Even though this unexpected TTF-1 positivity has been reported more frequently with the recently available SPT24 anti-TTF-1 monoclonal antibody, it has also been shown to occur with the commonly used 8G7G3/1 clone, albeit in a lower percentage of cases. Despite these findings, TTF-1 remains a very useful immunohistochemical marker in diagnostic pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531688     DOI: 10.1097/PAI.0b013e31825439bc

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  22 in total

Review 1.  Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms.

Authors:  Georgios Kyriakopoulos; Vasiliki Mavroeidi; Eleftherios Chatzellis; Gregory A Kaltsas; Krystallenia I Alexandraki
Journal:  Ann Transl Med       Date:  2018-06

2.  Thyroid transcription factor-1 expression in invasive and non-invasive urothelial carcinomas.

Authors:  S Sotiriou; N Koletsas; T Koletsa; S Touloupidis; M Lambropoulou
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

3.  Loss of cytokeratin 20 and acquisition of thyroid transcription factor-1 expression in a merkel cell carcinoma metastasis to the brain.

Authors:  Sara C Shalin; Christopher P Cifarelli; James Y Suen; Ling Gao
Journal:  Am J Dermatopathol       Date:  2014-11       Impact factor: 1.533

4.  Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels.

Authors:  Mauro G Silva; Nora L Falcoff; Gerardo R Corradi; Norma Di Camillo; Rolando F Seguel; Gabriela C Tabaj; Gabriela R Guman; Elena de Matteo; Myriam Nuñez; Mariela M Gironacci
Journal:  Pediatr Res       Date:  2022-06-23       Impact factor: 3.953

5.  Initial panel of immunocytochemical markers for identification of primary carcinoma site for effusions and peritoneal washings from women.

Authors:  Gustavo Henrique Soares Takano; Rivadávio Fernandes Amorim; Vânia Moraes Ferreira; Leonora Maciel de Souza Vianna; Tercia Maria Mendes Lousa de Castro; Marcos de Vasconcelos Carneiro; Ísis de Araújo Oliveira; Andrea Barretto Motoyama; Fabiana Pirani Carneiro
Journal:  Int J Clin Exp Pathol       Date:  2022-04-15

Review 6.  Immunohistochemical Biomarkers in Thyroid Pathology.

Authors:  Zubair Baloch; Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

7.  Metastatic Adenocarcinoma of Unknown Origin Presenting as Small Bowel Perforation: A Case Report and Literature Review.

Authors:  Samir Alkabie; Brian Bello; Roberto F Martinez; W Peter Geis; Michael S Ballo
Journal:  J Investig Med High Impact Case Rep       Date:  2015-03-23

8.  EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice.

Authors:  S Gahr; R Stoehr; E Geissinger; J H Ficker; W M Brueckl; A Gschwendtner; S Gattenloehner; F S Fuchs; C Schulz; R J Rieker; A Hartmann; P Ruemmele; W Dietmaier
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

9.  Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue.

Authors:  Konstantinos Kerkentzes; Vincenzo Lagani; Ioannis Tsamardinos; Mogens Vyberg; Oluf Dimitri Røe
Journal:  Front Oncol       Date:  2014-09-29       Impact factor: 6.244

10.  An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.

Authors:  Sonja Klebe; Adam Swalling; Lisa Jonavicius; Douglas W Henderson
Journal:  J Clin Pathol       Date:  2015-08-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.